posteditor

B Former Wisconsin Governor and U.S. Secretary of Health and Human Services Brings Extensive Healthcare Leadership to Pioneer of Transdermal Drug Delivery Technology MEQUON, Wis.,… Login to continue reading Login Sign up for complimentary access Sign Up Now Close

B NEW YORK, April 30, 2026 /PRNewswire/ — The Turks and Caicos Islands has long been the A-List’s best kept vacation secret, with pristine white… Login to continue reading Login Sign up for complimentary access Sign Up Now Close

B BIRMINGHAM, Ala., April 30, 2026 /PRNewswire/ — Storyteller Overland, the world’s most all-encompassing overland vehicle and adventure-ready lifestyle company, today announces a trailblazing partnership… Login to continue reading Login Sign up for complimentary access Sign Up Now Close

B NEW HAVEN, Conn., April 30, 2026 /PRNewswire/ — Yale School of Medicine (YSM) has received a $10 million gift from Bukhman Philanthropies, a London-based… Login to continue reading Login Sign up for complimentary access Sign Up Now Close

West Henrietta, NY – April 30, 2026 –Pharos Systems International has been awarded a Top Workplaces 2026 honor by The Rochester Democrat and Chronicle. This… Login to continue reading Login Sign up for complimentary access Sign Up Now Close

B NEW YORK, April 30, 2026 /PRNewswire/ — FesariusTherapeutics, Inc., a commercial stage bioregenerative technology company focused on the development, manufacture and commercialization of solutions… Login to continue reading Login Sign up for complimentary access Sign Up Now Close

B Strengthening clinical research capabilities in one of the nation’s most densely populated and high-opportunity oncology markets EAST BRUNSWICK, N.J., April 30, 2026 /PRNewswire/ —… Login to continue reading Login Sign up for complimentary access Sign Up Now Close

B Presentation details the impact of vapendavir on quality of life and lung function ATLANTA, April 30, 2026 /PRNewswire/ — Altesa BioSciences, a clinical-stage pharmaceutical company… Login to continue reading Login Sign up for complimentary access Sign Up Now Close

B – Bambusa’s lead product candidate, BBT001 is a next-generation long-acting bispecific antibody targeting two clinically and commercially validated targets, IL-4Rα and IL-31 for the… Login to continue reading Login Sign up for complimentary access Sign Up Now Close

B Strategic Transformation Drives Platform Expansion, Positions Company for Accelerated Growth TIANJIN, China, April 30, 2026 /PRNewswire/ — Taoping Inc. (Nasdaq: TAOP, the “Company”), a provider… Login to continue reading Login Sign up for complimentary access Sign Up Now Close